Family · Pharmaceutical analytical standards
Trimegestone
A synthetic progestin of the 19-norprogesterone family, described in 1979 and on the market since 2001 for menopausal hormone therapy, alone or together with estradiol. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?It was discovered as an active metabolite of another progestin, promegestone; developed in France, it was first marketed in Sweden.
No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
